Confirmed cases of COVID-19 variants identified in UK.

Public Health England (PHE); 2021.

Published on 16/4/2021


Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study.

Corman VM. The Lancet Microbe 2021;:https://doi.org/10.1016/S2666-5247(21)00056-2.

Published on 16/4/2021


Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Ramakrishnan S. The Lancet Respiratory Medicine 2021;:https://doi.org/10.1016/S2213-2600(21)00160-0.

Published on 16/4/2021


Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.

Graham MS. The Lancet Public Health 2021;:https://doi.org/10.1016/S2468-2667(21)00055-4.

Published on 16/4/2021


Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study.

Pham QD. The Lancet Global Health 2021;:https://doi.org/10.1016/S2214-109X(21)00103-0.

Published on 16/4/2021


Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis.

Rocha R. The Lancet Global Health 2021;:https://doi.org/10.1016/S2214-109X(21)00081-4.

Published on 16/4/2021


Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.

Frampton D. The Lancet Infectious Diseases 2021;:https://doi.org/10.1016/S1473-3099(21)00170-5.

Published on 16/4/2021


Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis.

Tsang NNY. The Lancet Infectious Diseases 2021;:https://doi.org/10.1016/S1473-3099(21)00146-8.

Published on 16/4/2021



1
2
3
4
...